
Sign up to save your podcasts
Or
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.
5
1212 ratings
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.
30,045 Listeners
40 Listeners
10 Listeners
0 Listeners
3,248 Listeners
3 Listeners
17 Listeners
2,238 Listeners